How it compares with Wegovy and Mounjaro The million-dollar question: could orforglipron give Wegovy or Mounjaro a run for its money
By geography, Brazil commanded 59.82% revenue in 2025, whereas Mexico is forecast to achieve a 10.57% CAGR during 2026-2031
C., Bhalla, M., Kean, B., Thomas, R
It is not for human or animal use, and not for therapeutic or diagnostic applications
Clinical manifestations can include acne, excessive body hair (caused by high androgen male hormone levels), irregular periods and infertility (due to infrequent or irregular ovulation), and metabolic issues, such as insulin resistance and metabolic syndrome, causing difficulties with weight management
Unlike the hormone your body produces, these medications are modified to resist breakdown by DPP-4, allowing them to remain active for much longeroften for days rather than minutes